BUY Sanofi India Limited — Kunal Saraogi
byKunal SaraogiHorizon: 1 year24 Jun 2026via Zee Business (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
2 other SEBI-registered advisors have active long-term BUY calls on this stock
Advisor consensus · same horizon·28 Jul · 3mo ago
Q2 FY27 results scheduled — board meets 29 Oct 2026
NSE · Board Meeting·In 5 days
Long-term trend bearish — 200-day average falling over the past quarter
Technicals · trend·23 Oct · yesterday
Sanofi India Limited has received a show cause notice from the GST authority.
NSE · Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company·29 Sept · 4w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Sanofi India
- BUY — Jefferies India28 Jul 2026 · ~1 year · target ₹3,500 · Active
- BUY — Sandeep Jain, Tradeswift24 Jul 2026 · ~1 year · target ₹4,000 · Active
More from Kunal Saraogi
- BUY IPCA Laboratories23 Oct 2026 · ~3 months · target ₹2,350 · Active
- BUY Firstsource Solutions23 Oct 2026 · ~2 weeks · target ₹299 · SL hit
- BUY L&T Technology Services22 Oct 2026 · ~2 weeks · target ₹4,600 · Active
- BUY Persistent Systems22 Oct 2026 · Same day · target ₹6,000 · SL hit
- BUY Oil India21 Oct 2026 · ~2 weeks · target ₹480 · Active

